Literature DB >> 6970064

Ristocetin-Willebrand factor activity in dog plasma.

I B Johnstone, F Lotz.   

Abstract

A sensitive and reproducible method for the quantitation of ristocetin-Willebrand factor activity in canine plasma is described. This assay measures the initial velocity of aggregation of suspensions of canine washed platelets in the presence of ristocetin and ristocetin-Willebrand factor. The washed platelets are stable for 4 h and when prepared from the same donor vary little in their day-to-day response to ristocetin. The calculated mean plasma ristocetin-Willebrand factor activity in 37 normal dogs using this method is 98 +/- 26% (mean +/- SD) Ristocetin-Willebrand activity is 106 +/- 25% in dogs with severe hemophilia A and 45 +/- 13% in dogs with moderate forms of von Willebrand's disease.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6970064     DOI: 10.1139/y80-170

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  5 in total

1.  The effects of desmopressin on plasma factor VIII/von Willebrand factor activity in dogs with von Willebrand's disease.

Authors:  I B Johnstone; S Crane
Journal:  Can J Vet Res       Date:  1987-04       Impact factor: 1.310

2.  Von Willebrand's disease in two families of Doberman Pinschers.

Authors:  I B Johnstone; S Crane
Journal:  Can Vet J       Date:  1981-08       Impact factor: 1.008

3.  Comparative effects of phenylbutazone, naproxen and flunixin meglumine on equine platelet aggregation and platelet factor 3 availability in vitro.

Authors:  I B Johnstone
Journal:  Can J Comp Med       Date:  1983-04

4.  Thrombokinetic studies in normal and factor VIII-deficient canine plasmas.

Authors:  I B Johnstone
Journal:  Can J Comp Med       Date:  1983-04

5.  Failure of sodium pentobarbital anesthesia to alter 1-desamino-8-D-arginine vasopressin-induced elevations of plasma factor VIII/ von Willebrand factor in normal dogs.

Authors:  I B Johnstone; S Crane
Journal:  Can J Vet Res       Date:  1988-10       Impact factor: 1.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.